Latest Articles

Publication Date
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment - TipRanks

Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment TipRanks

Published: Oct. 27, 2025, 6:32 p.m.
Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment - TipRanks

Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment TipRanks

Published: Oct. 27, 2025, 5:04 p.m.
Molecular mechanisms and Biological Functions of Autophagy in Endometrial Diseases.

Autophagy is a highly conserved cellular process crucial for maintaining cellular homeostasis by degrading damaged organelles and misfolded proteins. Emerging evidence highlights its pivotal role in endometrial diseases, including endometriosis, …

Published: Oct. 27, 2025, midnight
RND3 Inhibits Endometriosis Progression by Regulating Autophagy and Oxidative Stress Through PLEKHG5.

Endometriosis (EMS) is a chronic gynecological disease. RND3 is recognized as a potential autophagy-related biomarker in EMS. The aim of this study was to investigate the regulatory role of RND3 …

Published: Oct. 26, 2025, midnight
Serum Galectin-1 as a Diagnostic Biomarker in Endometriosis: A Prospective Longitudinal Study.

Endometriosis is a chronic condition characterized by the presence of endometrial-like tissue outside the uterine cavity. It affects ~10% of reproductive-aged individuals and is associated with dysmenorrhea and infertility. Although …

Published: Oct. 25, 2025, midnight
Ovarian mesonephric-like adenocarcinoma mimicking serous carcinoma: A case report integrating cytologic, frozen, histological, immunohistochemistry, and molecular analyses.

Mesonephric-like adenocarcinoma (MLA) is a recently recognized, rare subtype of endometrial carcinoma that can also arise in the ovary. Ovarian MLA is uncommon and often misdiagnosed due to its varied …

Published: Oct. 25, 2025, midnight
£5m pre-seed funding success sets up Cyclana Bio’s mission for women’s health - Cambridge Independent

£5m pre-seed funding success sets up Cyclana Bio’s mission for women’s health Cambridge Independent

Published: Oct. 23, 2025, 8 a.m.
Hypoxia-inducible factor-1 alpha expression in endometriosis: A retrospective observational case-control study of ovarian cyst capsules and endometrial tissue samples.

BackgroundThis study aimed to compare the expression patterns of hypoxia-inducible factor-1α in ovarian cyst capsules and endometrial tissue samples from patients with and without endometriosis to evaluate its potential as …

Published: Oct. 23, 2025, midnight
Improving Diagnostic Yield in Peritoneal Endometriosis: Value of Additional Level Sections and Sampling Protocols.

To evaluate whether deeper histologic sections and tissue-blocking practices improve the diagnosis of endometriosis in peritoneal biopsies. We retrospectively reviewed 148 peritoneal biopsy cases with clinical suspicion of endometriosis from …

Published: Oct. 23, 2025, midnight
It's not all in the name-how the misnomer 'endometriosis' stifles understanding and research.

Published: Oct. 22, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!